INTERNAL CLINICAL DEVELOPMENT PIPELINE
PROGRAM
THERAPEUTIC ENTITY
INDICATION
CURRENT STATUS
PROGRAM, THERAPEUTIC ENTITY, INDICATION, CURRENT STATUS
COMMERCIAL COLLABORATIONS
PARTNER
LICENSED TERRITORY
CURRENT STATUS
PARTNER, INDICATION, CURRENT STATUS
Greater China, South Korea, ASEAN Countries, India, Australia, New Zealand
Greater China, South Korea, ASEAN Countries, India, Australia, New Zealand
DEVELOPMENT AND COMMERCIAL COLLABORATIONS USING SCS MICROINJECTOR®
